States buy direct to save on drugs

Wisconsin is set to save $63 million on prescription drugs because it started buying directly--via a purchasing co-op--rather than paying HMOs to cover pharma costs. The co-op, which also includes Pennsylvania and Maryland, has enough bargaining power to negotiate rebates and other discounts off the "best wholesale price" drugmakers are bound by law to offer Medicaid programs. Part of the savings also comes from the use of "preferred drug lists," which steer doctors toward cheaper meds before allowing newer, costlier drugs to be prescribed.

The pharma industry has opposed these sorts of moves, saying that HMOs should be responsible for all aspects of a patient's care. Also, according to PhRMA, preferred drug lists can end up costing states more because they might require additional doctor visits and the like.

- read the story in the Milwaukee Journal-Sentinel

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.